Pfizer to invest $470m to develop research of coronavirus vaccine technology
Pfizer plans to spend $470 million to expand its vaccine research and development facilities in north-west of New…
Browsing Tag
BioNTech
Egypt agrees with GAVI to secure 20 million doses of candidate coronavirus vaccines
Egypt announced on Wednesday an agreement with the GAVI vaccine alliance to provide the country with 20 million…
Egypt reserves doses of anticipated Pfizer and Oxford trial coronavirus vaccines –…
Egypt has reserved doses of a potential coronavirus vaccine developed by Pfizer Inc and BioNTech that would cover…
Egypt’s stock market indices jump on coronavirus vaccine hopes
Gains on global shares have propelled Egypt’s stock exchange’s (EGX) indexes ending higher on Tuesday, with the…
World Health Organisation chief hails Pfizer coronavirus vaccine as…
The World Health Organisation (WHO) chief Tedros Adhanom Ghebreyesus on Monday hailed Pfizer and BioNTech's…
Pfizer, BioNTech may get $2 billion from US for 100 million doses of potential coronavirus…
The US government will pay $1.95 billion for Pfizer and BioNTech when the companies manufacture potential…
Pfizer, BioNTech shares surge after US deal of $2 billion for 100 million doses of…
Shares of both Pfizer and BioNTech surged; Pfizer jumped as much as 6 percent, while BioNTech rose nearly 8 percent…
U.S., Pfizer Inc. and BioNTech COVID-19 vaccine deal sets a ceiling for doses sale
The U.S., Pfizer Inc. and BioNTech SE are setting a price ceiling of less than $20 a dose after signing a $2…
BioNTech, Pfizer testing potential coronavirus vaccine, could “supply…
German drugmaker BioNTech and U.S. pharmaceutical giant Pfizer have begun human trials of a potential coronavirus…
Germany approves first human trials of new coronavirus vaccine
Germany’s Federal Institute for Vaccines has approved on Wednesday the first human trials of a potential…
